Clinicopathologic analysis revealed that high SNHG15 expression was associated with tumor differentiation, lymph node metastasis and tumor stage (p < 0.005), and patients with high SNHG15 expression had a shorter OS compared with the low SNHG15 expression group (p = 0.003). Here, SNHG15 is linked to neoplasm.